Fertility preservation: Difference between revisions
imported>TXJ (Created page with "{{disclaimer|The Nonbinary Wiki is written by volunteers who are not necessarily experts on medical topics. This wiki and its editors make no representations or warranties of...") |
imported>TXJ No edit summary |
||
Line 2: | Line 2: | ||
{{WIP|TXJ}} | {{WIP|TXJ}} | ||
'''Fertility preservation''', in the context of the trans and nonbinary community, means any steps taken by individuals to retain the option of having [[children]] who are biologically related to them. Some types of [[ | '''Fertility preservation''', in the context of the trans and nonbinary community, means any steps taken by individuals to retain the option of having [[children]] who are biologically related to them. Some types of [[hormone therapy]] or [[surgery]] will reduce or eliminate fertility either reversibly or irreversibly. Physicians often do not inform their patients about this, especially younger patients.<ref>{{cite journal|title=Preserving the Possibility of a Future Biological Family: State-Mandated Insurance Coverage of Fertility Preservation for Youth Patients When Primary Treatment Causes Sterility|last=Smith |first=Allison|year=2019|journal=Dukeminier Awards: Best Sexual Orientation Law Review Articles| volume=18|issue=1|pages=267-294}}</ref><ref name="Rafferty2019">{{cite journal|last1=Rafferty|first1=Jason|title=Fertility Preservation Outcomes and Considerations in Transgender and Gender-Diverse Youth|journal=Pediatrics|volume=144|issue=3|year=2019|pages=e20192000|issn=0031-4005|doi=10.1542/peds.2019-2000|url=https://pediatrics.aappublications.org/content/144/3/e20192000}}</ref> | ||
Some countries and states require transgender people to be sterilized (have their ovaries or testicles removed) in order to be [[Recognition|legally recognised]] as their self-identified gender. | |||
==Fertility preservation for people who were [[assigned female at birth]]== | |||
[[Masculinizing hormone therapy]] decreases ovulation and stops menstrual bleeding. However, people on masculinizing HRT may still become pregnant.<ref>{{cite journal | author = Krempasky C, Harris M, Abern L, Grimstad F | year = 2020 | title = Contraception across the transmasculine spectrum | url = https://www.ajog.org/article/S0002-9378(19)30955-X/fulltext | journal = The American Journal of Obstetrics and Gynecology| volume = 222 | issue = 2| pages = 134–143 | doi = 10.1016/j.ajog.2019.07.043 | pmid = 31394072 }}</ref> | |||
==Fertility preservation for people who were [[assigned male at birth]]== | |||
==References== | |||
{{reflist}} | |||
[[Category:Transition]] | [[Category:Transition]] |
Revision as of 18:25, 10 March 2021
TXJ is working on this article right now, so parts of the article might be inconsistent or not up to our standards of quality. You are welcome to help, but please ask in the talk page before performing significant changes to this page. Note to editors: If this notice stays here for more than two weeks, feel free to replace it with {{incomplete}} or a similar maintenance template. |
Fertility preservation, in the context of the trans and nonbinary community, means any steps taken by individuals to retain the option of having children who are biologically related to them. Some types of hormone therapy or surgery will reduce or eliminate fertility either reversibly or irreversibly. Physicians often do not inform their patients about this, especially younger patients.[1][2]
Some countries and states require transgender people to be sterilized (have their ovaries or testicles removed) in order to be legally recognised as their self-identified gender.
Fertility preservation for people who were assigned female at birth
Masculinizing hormone therapy decreases ovulation and stops menstrual bleeding. However, people on masculinizing HRT may still become pregnant.[3]
Fertility preservation for people who were assigned male at birth
References
- ↑ Smith, Allison (2019). "Preserving the Possibility of a Future Biological Family: State-Mandated Insurance Coverage of Fertility Preservation for Youth Patients When Primary Treatment Causes Sterility". Dukeminier Awards: Best Sexual Orientation Law Review Articles. 18 (1): 267–294.
- ↑ Rafferty, Jason (2019). "Fertility Preservation Outcomes and Considerations in Transgender and Gender-Diverse Youth". Pediatrics. 144 (3): e20192000. doi:10.1542/peds.2019-2000. ISSN 0031-4005.
- ↑ Krempasky C, Harris M, Abern L, Grimstad F (2020). "Contraception across the transmasculine spectrum". The American Journal of Obstetrics and Gynecology. 222 (2): 134–143. doi:10.1016/j.ajog.2019.07.043. PMID 31394072.CS1 maint: multiple names: authors list (link)